Perelman School of Medicine at the University of Pennsylvania

Penn Institute for Immunology

Cancer Immunology and Immunotherapy

The IFI Cancer Immunology research program aims to advance the understanding of the immune system's role in neoplastic pathophysiology. We are witnessing a transformational period of immunotherapies for cancer where not only are new discoveries being translated to the clinic with unprecedented efficiency, but studies in patients allow us to gain insights and define mechanisms in real time in patients as new therapies are introduced. Thus, our work spans basic science discoveries, to translational medicine, to clinical care and epidemiology. We utilize the most relevant state-of-the art technologies and model systems to catalyze our “bench to bedside” and then “back to the bench” approaches.

Cancer Immunology and Immunotherapy Members

Current Members

Cancer Immunology and Immunotherapy

Click the faculty member's name to see more detailed information.

Faculty

faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo
Michael Mitchell
faculty photo
faculty photo
faculty photo faculty photo faculty photo
faculty photo faculty photo faculty photo
faculty photo